Wells Fargo stock price heads into MLK weekend: WFC slips to $88.38 as debt filings stack up

Wells Fargo stock price heads into MLK weekend: WFC slips to $88.38 as debt filings stack up

New York, Jan 18, 2026, 14:50 EST — Market closed.

  • On Friday, Wells Fargo shares ended down 0.65%, closing at $88.38.
  • SEC filings reveal Wells Fargo arranged $2 billion in fixed-to-floating notes maturing in 2047, along with $500 million in floating-rate notes due 2030, with settlement set for Jan. 23.
  • Coming up: Tuesday’s reopening after the holiday, the Fed’s meeting on Jan. 27–28, and Wells Fargo speaking at a UBS conference on Feb. 10.

Wells Fargo & Co shares (WFC.N) slipped 0.65% on Friday, finishing at $88.38 and wrapping up the week with losses in bank stocks. Nasdaq

Wall Street will be closed Monday for Martin Luther King, Jr. Day, pushing the next U.S. equity session to Tuesday. That extra holiday can shift the focus, especially for rate-sensitive stocks, as traders often return ready to react sharply to macroeconomic cues. Nyse

Wells Fargo’s immediate challenge remains unchanged: the speed at which funding costs come down and if the yield curve behaves. At the same time, investors are sifting through new debt filings that, though standard for a major bank, feel tense in a market jittery over rates and spreads.

A prospectus filed on Jan. 16 revealed Wells Fargo plans to issue $2 billion in senior unsecured fixed-to-floating rate notes due Jan. 23, 2047, with settlement set for Jan. 23, 2026. The notes carry a 5.433% coupon until Jan. 23, 2046, after which the rate resets to Compounded SOFR plus 123 basis points. Sec

In another pricing supplement, the bank outlined terms for $500 million in senior redeemable floating rate notes maturing Jan. 23, 2030, with settlement on the same date. The coupon will be Compounded SOFR plus 74 basis points, according to the filing. Sec

SOFR, or the Secured Overnight Financing Rate, tracks overnight borrowing secured by U.S. Treasuries. One basis point equals 0.01 percentage points, meaning 123 basis points add up to 1.23 percentage points.

Friday’s session brought little relief for the sector. JPMorgan Chase (JPM.N) nudged up 1.04%, but Morgan Stanley (MS.N) dipped 1.12%, and Bank of New York Mellon (BK.N) dropped 2.13%. The S&P 500 slipped 0.06%. Marketwatch

Wells Fargo’s earnings report last week triggered a swift response from investors focused on interest rates. CEO Charlie Scharf told analysts, “The economy and our customers remain resilient.” Meanwhile, Brian Mulberry of Zacks Investment Management noted that “costs are under control and loan quality remains high.” Reuters

On the same call, CFO Michael Santomassimo said, “we currently expect total net interest income to be $50 billion, plus or minus, in 2026.” Net interest income is the difference between what a bank earns on loans and what it pays out on deposits and other funding. Fool

The stock’s next move might hinge on factors beyond anyone’s control: a surprise hawkish shift from the Fed, worsening credit conditions, or policy chatter rattling consumer lending. Bank shares have also been sensitive to discussions about a federal cap on credit card interest rates—something executives warn could dampen lending activity. Reuters

Investors are back Tuesday, gearing up for a bigger rate showdown at the Fed’s Jan. 27–28 meeting. Wells Fargo’s next public appearance is set for the UBS Financial Services Conference on Feb. 10. Federalreserve Wellsfargo

Stock Market Today

  • Medtronic advances into 2026 on diabetes spin-off, Hugo system, and steady dividends
    January 18, 2026, 4:43 PM EST. Medtronic (MDT) is trading on the prospect that a planned stand-alone spin-off of its diabetes business will sharpen focus on B2B operations and lift margins. Management has signaled the split should close by year-end 2026, reducing exposure to consumer diabetes care, which generated about 8% of revenue but only 4% of operating profit in fiscal 2025. A new growth driver comes from the Hugo robotic-assisted surgery (RAS) system, cleared in the U.S. for urologic procedures. While near-term top-line impact is modest, the device targets an underpenetrated market with long-term potential. Finally, Medtronic boasts a lengthy dividend streak, raising payouts for 48 consecutive years and offering about a 3% forward yield, with the potential to join the Dividend King club after 50 straight raises.
Lam Research stock rises into a holiday break — what LRCX investors watch next week
Previous Story

Lam Research stock rises into a holiday break — what LRCX investors watch next week

RTX stock hits fresh 52-week high as investors line up for Jan. 27 earnings
Next Story

RTX stock hits fresh 52-week high as investors line up for Jan. 27 earnings

Go toTop